| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
21,305 |
18,593 |
$1.24M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
10,026 |
9,189 |
$977K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
4,712 |
4,655 |
$637K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
3,469 |
3,324 |
$440K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,795 |
2,765 |
$339K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,258 |
1,241 |
$155K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
7,427 |
7,261 |
$142K |
| 90461 |
|
4,108 |
4,023 |
$65K |
| 97802 |
|
4,135 |
4,083 |
$52K |
| 90670 |
|
2,257 |
2,213 |
$44K |
| 90716 |
|
1,239 |
1,225 |
$31K |
| 99188 |
|
2,996 |
2,935 |
$30K |
| 99381 |
|
251 |
242 |
$23K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
6,605 |
6,194 |
$15K |
| 90671 |
|
271 |
270 |
$14K |
| 92567 |
|
1,823 |
1,665 |
$11K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
388 |
380 |
$8K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,734 |
1,669 |
$7K |
| 83655 |
|
1,914 |
1,848 |
$7K |
| 81003 |
|
5,202 |
5,087 |
$7K |
| 87430 |
|
388 |
384 |
$5K |
| 90651 |
|
284 |
281 |
$5K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
866 |
815 |
$5K |
| 17110 |
|
81 |
77 |
$4K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
78 |
76 |
$3K |
| 96127 |
|
992 |
928 |
$3K |
| 85018 |
|
3,012 |
2,943 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
442 |
364 |
$3K |
| 94667 |
|
298 |
293 |
$3K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
571 |
540 |
$2K |
| 87400 |
|
159 |
159 |
$2K |
| 87428 |
|
55 |
55 |
$2K |
| 90686 |
|
1,514 |
1,503 |
$2K |
| 87807 |
|
722 |
701 |
$1K |
| 90734 |
|
139 |
135 |
$1K |
| 90619 |
|
30 |
30 |
$945.05 |
| 90697 |
|
664 |
654 |
$683.35 |
| 96160 |
|
587 |
585 |
$660.26 |
| 90707 |
|
1,233 |
1,216 |
$560.33 |
| 90696 |
|
347 |
343 |
$498.50 |
| 94664 |
|
196 |
193 |
$488.01 |
| 69210 |
|
232 |
218 |
$435.59 |
| 90633 |
|
1,546 |
1,530 |
$410.73 |
| 81025 |
|
57 |
55 |
$347.15 |
| 90620 |
|
52 |
52 |
$243.76 |
| 90685 |
|
99 |
99 |
$178.72 |
| 92551 |
|
4,223 |
3,777 |
$141.18 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
12 |
12 |
$130.68 |
| 36416 |
|
2,723 |
2,547 |
$123.91 |
| 87420 |
|
12 |
12 |
$98.34 |
| 94760 |
|
51 |
49 |
$84.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
46 |
45 |
$47.48 |
| 90723 |
|
1,269 |
1,234 |
$40.00 |
| 90680 |
|
1,940 |
1,898 |
$30.00 |
| 96161 |
|
52 |
52 |
$10.28 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
37 |
36 |
$2.92 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
159 |
150 |
$0.24 |
| 90647 |
|
1,356 |
1,333 |
$0.00 |
| 90677 |
|
203 |
197 |
$0.00 |
| 99173 |
|
1,254 |
1,224 |
$0.00 |
| 90700 |
|
351 |
348 |
$0.00 |
| 90715 |
|
53 |
52 |
$0.00 |
| 99051 |
|
13 |
13 |
$0.00 |
| 90621 |
|
16 |
16 |
$0.00 |
| 99177 |
|
3,681 |
3,219 |
$0.00 |
| 99401 |
|
26 |
26 |
$0.00 |